Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 21, 2020; 26(27): 3851-3864
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3851
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3851
Diagnosis | ADA criteria |
Diabetes | FPG ≥ 126 mg/dL (7.0 mmol/L). Fasting is defined as no caloric intake for at least 8 h.1 OR |
2-h PG ≥ 200 mg/dL (11.1 mmol/L) during OGTT. The test should be performed as described by the WHO, using a glucose load containing the equivalent of 75-g anhydrous glucose dissolved in water.1 OR | |
A1C ≥ 6.5% (48 mmol/mol). The test should be performed in a laboratory using a method that is NGSP certified and standardized to the DCCT assay.1 OR | |
in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, an RPG ≥ 200 mg/dL (11.1 mmol/L). | |
Prediabetes | FPG 5.6-6.9 mmol/L (100-125mg/dL) (IFG) OR |
2HPG 7.8-11.0 mmol/L(IGT) OR | |
A1c 5.7%-6.4% |
- Citation: Shen T, Zhuang L, Sun XD, Qi XS, Wang ZH, Li RD, Chang WX, Yang JY, Yang Y, Zheng SS, Xu X. Expert consensus on management of metabolic disease in Chinese liver transplant recipients. World J Gastroenterol 2020; 26(27): 3851-3864
- URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3851.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i27.3851